United States: What's New For CMS Bundled Payments Program

On April 24, 2019, the Centers for Medicare & Medicaid Services released a request for applications for the Bundled Payments for Care Improvement Advanced model for its second cohort of applicants since the program's inception.1

BPCI Advanced is an initiative of CMS' Center for Medicare & Medicaid Innovation, and is designed to increase participation in voluntary bundled payment models.2 BPCI Advanced commenced for the first cohort of participants on Oct. 1, 2018, and the second cohort will begin participation on Jan. 1, 2020 for model year 3.3 As CMS does not anticipate issuing additional requests for applications for model years 4 (2021) through 6 (2023), this may be the last opportunity for stakeholders to participate in BPCI Advanced as conveners or nonconvener participants contracting with CMS.

New applicants have until June 24, 2019, to apply. Current BPCI Advanced participants had until June 1, 2019, to execute an optional amendment to the initial BPCI Advanced agreement, which was recently released by CMS. 

The implications of the proposed amendment, and basis for CMS' changes, are discussed in further detail below.

BPCI Advanced Model

With BPCI Advanced, CMS is testing an alternative payment model that uses bundled payments tied to stakeholder performance on quality measures as a means to incentivize financial accountability, care redesign, data analysis and feedback, as well as provider, caregiver and patient engagement.4 BPCI Advanced uses a retrospective bundled payment approach, meaning that stakeholders continue to receive customary fee-for-service payments for all items and services within a given clinical episode, and the total nonexcluded Medicare fee-for-service expenditures are reconciled against a predetermined target price for that clinical episode.5

On an annual basis, CMS pays stakeholders a net payment reconciliation amount payment if the fee-for-service expenditures for all episodes treated during the year are less than the targeted price for those episodes, or, if the fee-for-service expenditures for all episodes treated during the year exceed the targeted price for those episodes, the stakeholders pay CMS a repayment amount.6

Some stakeholders may apply to become a "participant," which is an entity that enters into the BPCI Advanced model agreement with CMS. CMS requires all participants to take on downside financial risk (i.e., to agree to pay the repayment amount if actual fee-for-service expenditures exceed targeted prices) from the outset, and classifies them into two categories: convener participants and nonconvener participants. Both categories of participants may enter into relationships with downstream physicians and nonphysician practitioners to share the net payment reconciliation amount payment or to apportion responsibility for the repayment amounts, if any. There are, however, differences between conveners and nonconveners, for which we provide a high-level summary below.

Convener Participants

Convener participants must bear full financial risk to CMS on behalf of at least one acute care hospital or physician group practice, and must enter into an agreement with a physician group practice or acute care hospital that requires the physician group practice or acute care hospital to adhere to the terms of the BPCI Advanced model agreement. CMS further classifies physician group practices and acute care hospitals participating in BPCI Advanced as "downstream episode initiators" responsible for triggering the clinical episode for which the convener participant is ultimately financially responsible.

Nonconvener Participants

Only physician group practices and acute care hospitals may act as nonconvener participants. In these arrangements with CMS, the nonconvener participant bears full financial risk only for themselves, and the nonconvener participant initiates the episode of care for which the nonconvener participant is responsible.7

The BPCI Advanced Model Year 3 Timeline[8]

To apply to participate, applicants must submit their materials to CMS through the BPCI Advanced application portal.8 After CMS selects the applicants based on their submitted materials, the applicants must pass a required provider vetting process, in addition to law enforcement screenings before they can participate.

April 24, 2019: CMS posted the request for applications, and the application submission period began for the second cohort of participants.

June 24, 2019: The application period ends.

June to July 2019: CMS reviews applications.

September 2019: CMS distributes the model year 3 participation agreements to selected applicants.

November 2019: The selected applicants sign and submit the participation agreements in addition to their participant profile.

December 2019: The selected participants must submit all deliverables for Quarter 1 2020 to CMS. (The required deliverables include the following: Participant profile due about 60 days prior to the start of the model year; the care redesign plan due about 30 days before the start of the model year; and the quality payment program list and financial arrangement list, which are both due about 30 days before the start of the quarter.)9

Jan. 1, 2020: Model year 3 begins, and the second cohort of participants starts providing services through the BPCI Advanced.10

Model Year 3 Changes

The request for applications released by CMS includes certain changes to BPCI Advanced for model year 3 compared to model years 1 and 2. Specifically, more clinical episodes are available for model year 3 (37 instead of 32)11 and stakeholders have more flexibility with respect to quality measures. CMS may permit participants to choose either the administrative quality measures set, which contains the quality measures used in 2018 and 2019, or an alternate quality measures set.12

The alternative quality measures will include both claims-based and registry-based (i.e., a tailored set of quality measures for each specialty specific clinical episode) measures, as opposed to only claims-based measures used for the administrative quality measures.13 CMS will use the same calculation methodology to assess the quality measures, regardless of the quality measure set the new participants select. CMS aims to release the alternate quality measures for model year 3 prior to June 24, 2019, when the application period ends.14

In addition to the changes reflected in the request for applications for model year 3, CMS has offered current participants the option to amend their existing BPCI Advanced model agreements. The recently released amendment — which would be effective upon execution (and presumably will be incorporated automatically into the model agreements for new participants in model year 3) — includes the following changes:

  • Elimination of the 50% cap on net payment reconciliation amount sharing payments, which some believed weakened the financial incentive for physician group practices and acute care hospitals to act as a convener participant;
  • Changes to allow convener participants with downstream episode initiators to avoid the need for a secondary repayment source (which must consist of funds held in escrow or a letter of credit) if all of the participant's downstream episode initiators enter into agreements allowing CMS to collect repayment amounts owed by the convener participant through reduction of Medicare payments otherwise owing to the downstream episode initiators;
  • Elimination of the one-year reapplication waiting period for participants who terminate the agreement early;
  • Changes to the reporting mechanism through which CMS tracks participation in the quality payment program, to allow all eligible clinicians participating in BPCI Advanced (including physicians and nonphysician practitioners) to be assessed for quality payment determinations and scored under the advanced payment model scoring standard; and
  • Expansion of the existing telehealth payment policy waiver to allow Medicare payment for telehealth services regardless of whether the service is furnished to a BPCI Advanced beneficiary located in a telehealth originating site, provided that the telehealth service is furnished to a BPCI Advanced beneficiary in their home or place of residence during a BPCI Advanced clinical episode by an eligible provider.

CMS sent participants the amendment, which participants had to sign by June 1, 2019, if they wished to take advantage of the recent changes.

Amendment Implications

The amendment signaled an acknowledgment by CMS of industry dissatisfaction and concern with the initial BPCI Advanced structure, and in particular, its 50% cap on net payment reconciliation amount sharing payments. Stakeholders have argued that the 50% cap substantially reduced the appeal for high-functioning physician group practices or acute care hospitals to participate in BPCI Advanced as downstream episode initiators — where they may focus exclusively on care coordination, quality improvement and cost management, rather than network development and oversight. 

In turn, the initial program structure incentivized these physician group practices and acute care hospitals to act as participants, which are not subject to the cap.  The amendment and elimination of the 50% cap highlights the value physician group practices and acute care hospitals provide to BPCI Advanced as downstream episode initiators, as well as the efficiencies created by legacy participants with whom they contract and have substantial experience in day-to-day oversight across participating providers.

The amendment further expanded opportunities for participants to allocate financial risk across their downstream episode initiators, and eliminated certain administrative burdens associated with CMS repayment amount collections. The original BPCI Advanced agreement held participants directly responsible for repayment amounts and imposed onerous requirements in order to ensure participants maintained adequate access to capital throughout the arrangement's term, on behalf of itself and its downstream episode initiators.

The amendment, however, now permits downstream episode initiators to provide CMS with the express right to collect any outstanding repayment amount by reducing independent Medicare payments. Provided that all contracted downstream episode initiator arrangements include such provisions, CMS has alleviated the secondary repayment source requirements imposed upon applicable participants. Further presuming that this same change is included in the model 3 BPCI Advanced agreement, program participation as a participant convener or nonconvener participant could be appealing to organizations with more limited financial resources.  Conversely, however, networks that do not require direct risk assumption by downstream episode initiators may become more appealing for physician group practices and acute care hospitals. 

In addition to alleviating secondary repayment source requirements and eliminating the 50% cap on net payment reconciliation amount, the amendment resolves ambiguity surrounding the impact of a convener participant's decision to terminate the BPCI Advanced agreement early.

Before the amendment, if a participant elected to terminate the BPCI Advanced agreement early for any reason, CMS would impose a one-year waiting period before such participant could "reapply" to participate in BPCI Advanced. However, it was unclear whether the one-year waiting period on "reapply[ing]" would prohibit a convener participant from applying with an entirely different set of downstream episode initiators.

When CMS indicated that the one-year waiting period would indeed apply to convener participants seeking to participate with different downstream episode initiators,15 many convener participants promptly objected. CMS in turn issued guidance prior to a March 1, 2019, deadline in connection with the one-time "Retroactive Withdrawal Policy" that the waiting period would not prohibit convener participants from applying for model year 3, thus freeing up convener participants — many of whom have multiple BPCI Advanced agreements in place with CMS — to terminate (whether retroactively by the March 1 deadline, or prospectively for other terminations) some or all such agreements without fear of being locked out of the model year 3 enrollment period. The amendment now formally eliminates the one-year waiting period altogether.

Finally, the amendment signals CMS' move towards a simpler, more flexible BPCI Advanced program with changes to QPP list requirements and the program's telehealth waiver. With respect to the QPP list, the amendment imposes streamlined documentation submission requirements in order to better conform with requirements of the Medicare Access and CHIP Reauthorization Act of 2015 and reduce participant administrative costs.

Additionally, CMS broadened the telehealth waiver to include services furnished at any BPCI Advanced beneficiary's home may allow for greater access to BPCI Advanced for more beneficiaries, tracking CMS' broader initiatives to loosen telehealth access requirements for Medicare and Medicaid participants.

Footnote

1 CMS, BPCI Advanced: Applicant Res. (last visited May 1, 2019), https://innovation.cms.gov/initiatives/bpci-advanced/applicant-resources.html#applicant.

2 Id.

3 Id.

4 CMS, Request for Applications, BPCI Advanced for Model Year 3, 3-4 (April 18, 2019), available at https://innovation.cms.gov/Files/x/bpciadvanced-my3-rfa.pdf.

5 An overview of key features and program logistics of BPCI Advanced is available at the following link: https://www.ropesgray.com/en/newsroom/alerts/2018/02/What-To-Know-About-CMS-New-Bundled-Payment-Model.

6 Id.

7 CMS, General FAQs – BPCI Advanced Model Year 3, Question 4 (Apr. 2019), https://innovation.cms.gov/Files/x/bpciadvanced-general-faq.pdf.

8 CMS,BPCI Advanced: Applicant Resources(May 1, 2019), https://innovation.cms.gov/initiatives/bpci-advanced/applicant-resources.html#applicant.

9 CMS, Application Road Map – Model Year 3 (last visited May 1, 2019), https://innovation.cms.gov/Files/x/bpci-advanced-my3-app-roadmap.pdf. CMS notes all dates are subject to change.

10 CMS, General FAQs – BPCI Advanced Model Year 3, Question 29 (Apr. 2019), https://innovation.cms.gov/Files/x/bpciadvanced-general-faq.pdf.

11 The added clinical episodes for Model Year 3 include: Bariatric Surgery; Inflammatory Bowel Disease; Seizures; Transcatheter Aortic Valve Replacement; and Major joint replacement of the lower extremity. CMS, General FAQs – BPCI Advanced Model Year 3, Question 10 (Apr. 2019) https://innovation.cms.gov/Files/x/bpciadvanced-general-faq.pdf.

12 CMS, Request for Applications, BPCI Advanced for Model Year 3, Appendix B (Apr. 18, 2019), https://innovation.cms.gov/Files/x/bpciadvanced-my3-rfa.pdf.

13 Id.

14 BPCI Advanced, (May 1, 2019), https://innovation.cms.gov/initiatives/bpci-advanced.

15 CMS, CMS Statement Regarding the Retroactive Withdrawal Policy and the new Participation Agreement for BPCI Advanced, 1 (August 1, 2018), available at: https://innovation.cms.gov/Files/x/bpciadvanced-withdrawl-participation.pdf.

Originally published by Law360

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
Similar Articles
Relevancy Powered by MondaqAI
Akin Gump Strauss Hauer & Feld LLP
 
In association with
Related Topics
 
Similar Articles
Relevancy Powered by MondaqAI
Akin Gump Strauss Hauer & Feld LLP
Related Articles
 
Related Video
Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Mondaq Free Registration
Gain access to Mondaq global archive of over 375,000 articles covering 200 countries with a personalised News Alert and automatic login on this device.
Mondaq News Alert (some suggested topics and region)
Select Topics
Registration (please scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.

Disclaimer

The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.

General

Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions